Cargando…

New Advances in Alzheimer's Disease: From Biology to Therapy

Detalles Bibliográficos
Autor principal:	Tesco, Giuseppina
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd. 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647164/ https://www.ncbi.nlm.nih.gov/pubmed/19415124 http://dx.doi.org/10.2174/138920207783769558

Ejemplares similares

Molecular mechanisms of cognitive dysfunction following traumatic brain injury
por: Walker, Kendall R., et al.
Publicado: (2013)

Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo
por: Kim, WonHee, et al.
Publicado: (2021)

Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice
por: Kittelberger, Kara A., et al.
Publicado: (2012)

The Biology of Glial Cells and Their Complex Roles in Alzheimer’s Disease: New Opportunities in Therapy
por: Nirzhor, Saif Shahriar Rahman, et al.
Publicado: (2018)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
por: Bakota, Lidia, et al.
Publicado: (2016)

Advances in the development of new biomarkers for Alzheimer’s disease
por: Klyucherev, Timofey O., et al.
Publicado: (2022)

Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
por: Hussein, Weiam, et al.
Publicado: (2018)

Advances in stromal cell therapy for management of Alzheimer’s disease
por: Srivastava, Rashi, et al.
Publicado: (2022)

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
por: Giuseppina, Talarico, et al.
Publicado: (2019)

Genetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission
por: Walker, Kendall R., et al.
Publicado: (2016)

Alzheimer's disease: new diagnostic and therapeutic tools
por: Racchi, Marco, et al.
Publicado: (2008)

BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice
por: Kim, WonHee, et al.
Publicado: (2018)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Advances in Alzheimer's Disease: From Bench to Bedside
por: Jiang, Teng, et al.
Publicado: (2015)

Advances in the prevention of Alzheimer's Disease
por: Sindi, Shireen, et al.
Publicado: (2015)

Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016)

Advances in Alzheimer’s Disease-Associated Aβ Therapy Based on Peptide
por: Wang, Cunli, et al.
Publicado: (2023)

Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
por: Kim, Duk Hwan, et al.
Publicado: (2017)

Immunosenescence, inflammation and Alzheimer’s disease
por: Martorana, Adriana, et al.
Publicado: (2012)

Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease
por: Stites, Shana D., et al.
Publicado: (2018)

Herbal therapy: a new pathway for the treatment of Alzheimer's disease
por: Tian, Jinzhou, et al.
Publicado: (2010)

R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2022)

Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer’s Disease
por: Campora, Marta, et al.
Publicado: (2021)

Effects of Dog-Assisted Therapies on Cognitive Mnemonic Capabilities in People Affected by Alzheimer’s Disease
por: Quintavalla, Fausto, et al.
Publicado: (2021)

Matrix metalloproteinase 13, a new target for therapy in Alzheimer's disease
por: Paumier, Jean-Michel, et al.
Publicado: (2019)

Genetics of Alzheimer's disease: recent advances
por: Avramopoulos, Dimitrios
Publicado: (2009)

Advances in Alzheimer’s Disease Drug Development
por: Rafii, Michael S, et al.
Publicado: (2015)

Advances in screening instruments for Alzheimer's disease
por: Zhou, Xianbo, et al.
Publicado: (2019)

Recent Advances in the Modeling of Alzheimer’s Disease
por: Sasaguri, Hiroki, et al.
Publicado: (2022)

Advances in Alzheimer’s disease’s pharmacological treatment
por: Conti Filho, Carlos Elias, et al.
Publicado: (2023)

The biological pathways of Alzheimer disease: a review
por: Calabrò, Marco, et al.
Publicado: (2020)

Recent Advances from the Bench Toward the Bedside in Alzheimer's Disease
por: Macauley, Shannon L., et al.
Publicado: (2015)

Biological Markers and Alzheimer Disease: A Canadian Perspective
por: Schipper, Hyman M.
Publicado: (2010)

Clinical, Biological, and Imaging Features of Monogenic Alzheimer's Disease
por: Pilotto, Andrea, et al.
Publicado: (2013)

Antioxidant Therapies for Alzheimer's Disease
por: Feng, Ye, et al.
Publicado: (2012)

Antidiabetic therapies and Alzheimer disease
por: Bendlin, Barbara B
Publicado: (2019)

A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
por: Hajjo, Rima, et al.
Publicado: (2022)

Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration
por: Amadoro, Giuseppina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hpknt01kqf8782gm15ukb7cbck